Proactiveinvestors United Kingdom RNS press releases https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom RNS press releases RSS feed en Wed, 20 Mar 2019 05:33:10 +0000 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[RNS press release - Positive decision on Feraccru®'s process patent ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190314153122_14002924 Thu, 14 Mar 2019 15:31:22 +0000 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190314153122_14002924 <![CDATA[RNS press release - Positive results for Feraccru® in AEGIS-H2H study ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190304070007_13988235 Mon, 04 Mar 2019 07:00:07 +0000 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190304070007_13988235 <![CDATA[RNS press release - Positive results of AEGIS-CKD study ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190129070007_13949532 Tue, 29 Jan 2019 07:00:07 +0000 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190129070007_13949532 <![CDATA[RNS press release - Business and trading update ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190124070005_13944846 Thu, 24 Jan 2019 07:00:05 +0000 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190124070005_13944846 <![CDATA[RNS press release - Investor presentations ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190123101939_13944165 Wed, 23 Jan 2019 10:19:39 +0000 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190123101939_13944165 <![CDATA[RNS press release - Appointment of Chairman ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190122070009_13942030 Tue, 22 Jan 2019 07:00:09 +0000 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190122070009_13942030 <![CDATA[RNS press release - US New Drug Application PDUFA date for Feraccru ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20181213070002_13901818 Thu, 13 Dec 2018 07:00:02 +0000 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20181213070002_13901818 <![CDATA[RNS press release - UK launch of Feraccru® by Norgine ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20181205100441_13892355 Wed, 05 Dec 2018 10:04:41 +0000 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20181205100441_13892355 <![CDATA[RNS press release - New Drug Application for Feraccru® ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20181203070008_13887987 Mon, 03 Dec 2018 07:00:08 +0000 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20181203070008_13887987 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20181109154623_13862263 Fri, 09 Nov 2018 15:46:23 +0000 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20181109154623_13862263 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20181108182109_13860819 Thu, 08 Nov 2018 18:21:09 +0000 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20181108182109_13860819 <![CDATA[RNS press release - Notification Of Major Holdings ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20181001135409_13811521 Mon, 01 Oct 2018 13:54:09 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20181001135409_13811521 <![CDATA[RNS press release - Submission of an NDA for Feraccru® with the FDA ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20181001070005_13810092 Mon, 01 Oct 2018 07:00:05 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20181001070005_13810092 <![CDATA[RNS press release - Director/PDMR Shareholding ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20180924130635_13802120 Mon, 24 Sep 2018 13:06:35 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20180924130635_13802120 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20180924130225_13802116 Mon, 24 Sep 2018 13:02:25 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20180924130225_13802116 <![CDATA[RNS press release - Licence for the commercialisation of Feraccru ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20180919071450_13796195 Wed, 19 Sep 2018 07:14:50 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20180919071450_13796195 <![CDATA[RNS press release - Interim Results ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20180919071256_13796192 Wed, 19 Sep 2018 07:12:56 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20180919071256_13796192 <![CDATA[RNS press release - AEGIS-H2H Completion of Recruitment ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20180913070007_13788901 Thu, 13 Sep 2018 07:00:07 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20180913070007_13788901 <![CDATA[RNS press release - Appointment of Non-Executive Director ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20180726070023_13731795 Thu, 26 Jul 2018 07:00:23 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20180726070023_13731795 <![CDATA[RNS press release - Business Update ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20180723070006_13726709 Mon, 23 Jul 2018 07:00:06 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20180723070006_13726709